Surgery Partners, INC Form 4 insider transactions

Harrison R. Bane, National Group President of Surgery Partners, Inc., sold 4,045 shares of common stock to cover tax withholding obligations.

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, Inc., sold 3,008 shares of common stock to cover tax withholding obligations related to vesting restricted stock.

Danielle Burkhalter, Chief Human Resources Officer of Surgery Partners, Inc., sold 1,240 shares of common stock on March 10, 2025, to satisfy tax withholding obligations related to vesting restricted stock.

William Trenton Webb, American Group President at Surgery Partners, Inc., sold 2,057 shares of common stock to cover tax obligations related to vesting restricted stock.

David T. Doherty, CFO of Surgery Partners, Inc., sold 6,733 shares of common stock on March 10, 2025, to satisfy tax withholding obligations related to vesting restricted stock.

Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc., sold 3,156 shares of common stock on March 10, 2025, to satisfy tax withholding obligations related to vesting restricted stock.

William Trenton Webb, an officer at Surgery Partners, Inc., acquired shares of common stock through restricted stock awards on March 4, 2025.

Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc., reports the acquisition of restricted stock awards.

Harrison R. Bane, National Group President at Surgery Partners, Inc., reports the acquisition of restricted stock awards on March 4, 2025.

Danielle Burkhalter, Chief Human Resources Officer at Surgery Partners, Inc., reports the acquisition of restricted stock awards.

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, Inc., reports the acquisition of restricted stock awards on March 4, 2025.

David T. Doherty, CFO of Surgery Partners, Inc., was granted restricted stock awards on March 4, 2025, according to a Form 4 filing.

Jason Eric Evans, CEO of Surgery Partners, Inc., reports the acquisition of restricted stock awards on March 4, 2025.

Harrison R. Bane, National Group President of Surgery Partners, Inc., sold 56,315 shares of common stock to cover tax obligations related to vesting restricted stock.

David T. Doherty, CFO of Surgery Partners, Inc., sold 13,641 shares of common stock on February 7, 2025, to satisfy tax withholding obligations related to vesting restricted stock.

Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc., sold 14,700 shares of common stock on February 7, 2025, to cover tax obligations related to the vesting of restricted stock.

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, sold 5,681 shares of common stock on February 7, 2025, to cover tax obligations related to vesting restricted stock.

Surgery Partners CEO Jason Eric Evans sold 26,520 shares of common stock on February 7, 2025, to satisfy tax withholding obligations related to the vesting of restricted stock.

William Trenton Webb, American Group President at Surgery Partners, acquired shares through performance vesting and sold a portion to cover tax obligations.

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, acquired 22,209 shares of common stock on January 31, 2025, following the satisfaction of performance vesting criteria.

Harrison R. Bane, National Group President of Surgery Partners, Inc., acquired 115,116 shares of common stock on January 31, 2025, following the satisfaction of performance vesting criteria.

David T. Doherty, CFO of Surgery Partners, Inc., acquired 26,784 shares of common stock on January 31, 2025, following the satisfaction of performance vesting criteria.

Jason Eric Evans, CEO of Surgery Partners, Inc., acquired 111,048 shares of common stock on January 31, 2025, following the satisfaction of performance vesting criteria.

Marissa Brittenham, Chief Strategy Officer of Surgery Partners, acquired 25,110 shares of common stock on January 31, 2025, following the vesting of performance stock units.

Danielle Burkhalter, Chief Human Resources Officer of Surgery Partners, Inc., sold 167 shares of common stock on February 4, 2025, to satisfy tax withholding obligations related to the vesting of restricted stock.

Surgery Partners CEO, Jason Eric Evans, exercised stock options to acquire 16,500 shares of common stock at a price of $11.54 per share.

Harrison R. Bane, National Group President at Surgery Partners, Inc., reports acquisition and disposal of company stock related to restricted stock awards and tax obligations.

William Trenton Webb, American Group President at Surgery Partners, acquired 1,877 shares of common stock through a restricted stock award on September 1, 2024.

Danielle Burkhalter, Chief Human Resources Officer of Surgery Partners, Inc., sold 6,000 shares of common stock at a price of $26.385 per share on June 12, 2024.

Patricia Anne Maryland, a director at Surgery Partners, acquired 6,170 shares of common stock on June 6, 2024, at a price of $25.93 per share.